These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18393118)

  • 21. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of bare metal stent in drug eluting stent era].
    Takizawa K; Inoue N
    Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ['Protective' stent implantation in a patient with acute coronary syndrome without ST segment elevation complicated by in stent thrombosis].
    Romanek R; Grzelakowski P; Formuszewicz R; Ługowski T; Wnuk T; Olechnicki M; Rusicka-Piekarz T; Goch A
    Kardiol Pol; 2010 Jan; 68(1):108-10; discussion 111. PubMed ID: 20131199
    [No Abstract]   [Full Text] [Related]  

  • 25. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Aoki J; Lansky AJ; Mehran R; Moses J; Bertrand ME; McLaurin BT; Cox DA; Lincoff AM; Ohman EM; White HD; Parise H; Leon MB; Stone GW
    Circulation; 2009 Feb; 119(5):687-98. PubMed ID: 19171852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent very late stent thrombosis after bare-metal stent implantation.
    Saito T; Asajima H
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):51-3. PubMed ID: 17295327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
    Kukreja N; Onuma Y; Garcia-Garcia HM; Daemen J; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jun; 2(6):534-41. PubMed ID: 19539258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
    Rigattieri S; Patrizi R; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Palamara A; Loschiavo P
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):771-4. PubMed ID: 17001240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P; Motovska Z; Belardi J; Serruys P; Silber S; Windecker S; Neumann FJ
    Int J Cardiol; 2013 Oct; 168(4):3522-6. PubMed ID: 23706326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time does not heal every wound: coronary stent thrombosis of a bare-metal stent more than one decade after its implantation.
    Zomer AC; Zwart B; van Werkum JW; Suttorp MJ
    Platelets; 2009 Dec; 20(8):594-7. PubMed ID: 19857047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
    Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
    Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis and acute myocardial infarction as consequences of very late stent malapposition after implantation of a drug-eluting stent.
    Park JS; Kim YJ; Hong GR
    J Invasive Cardiol; 2007 Jun; 19(6):E163-5. PubMed ID: 17541139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late coronary stent thrombosis.
    Thuesen L; Holm NR
    Minerva Med; 2010 Feb; 101(1):25-33. PubMed ID: 20228718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
    Räber L; Magro M; Stefanini GG; Kalesan B; van Domburg RT; Onuma Y; Wenaweser P; Daemen J; Meier B; Jüni P; Serruys PW; Windecker S
    Circulation; 2012 Mar; 125(9):1110-21. PubMed ID: 22302840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
    Brodie BR; Garg A; Stuckey TD; Kirtane AJ; Witzenbichler B; Maehara A; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Mehran R; Parvataneni R; Stone GW
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26415600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?
    Bollati M; Biondi-Zoccai GG; Gambino A; Lombardi P; Sheiban I
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):403-5. PubMed ID: 18334896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.